Your browser doesn't support javascript.
loading
2018 consensus statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the diagnosis and treatment of cancer of unknown primary
Losa, F; Iglesias, L; Pané, M; Sanz, J; Nieto, B; Fusté, V; Cruz-Merino, L de la; Concha, Á; Balañá, C; Matías-Guiu, X.
Afiliación
  • Losa, F; Institut Català d'Oncologia ICO. Medical Oncology Department. Sant Joan Despí. España
  • Iglesias, L; Hospital Universitario Doce de Octubre. Medical Oncology Department. Madrid. Spain
  • Pané, M; Hospital Universitari de Bellvitge. Pathology Department. L'Hospitalet de Llobregat. Spain
  • Sanz, J; Hospital Clínico San Carlos. Pathology Department. Madrid. Spain
  • Nieto, B; Hospital Universitario de León. Medical Oncology Department. León. Spain
  • Fusté, V; Hospital de la Santa Creu i Sant Pau. Pathology Department. Barcelona. Spain
  • Cruz-Merino, L de la; Hospital Universitario Virgen Macarena. Medical Oncology Department. Seville. Spain
  • Concha, Á; Hospital Universitario A Coruña. Pathology Department. La Coruña. Spain
  • Balañá, C; Institut Català d'Oncologia. Medical Oncology Department. Badalona. Spain
  • Matías-Guiu, X; Centro de Investigación Biomédica en Red Cáncer (CIBERONC). L'Hospitalet de Llobregat. Spain
Clin. transl. oncol. (Print) ; 20(11): 1361-1372, nov. 2018. ilus, tab, graf
Article en En | IBECS | ID: ibc-173726
Biblioteca responsable: ES1.1
Ubicación: BNCS
ABSTRACT
Cancer of unknown primary (CUP) is defined as a heterogeneous group of tumours that present with metastasis, and in which attempts to identify the original site have failed. They differ from other primary tumours in their biological features and how they spread, which means that they can be considered a separate entity. There are several hypotheses regarding their origin, but the most plausible explanation for their aggressiveness and chemoresistance seems to involve chromosomal instability. Depending on the type of study done, CUP can account for 2-9% of all cancer patients, mostly 60-75 years old. This article reviews the main clinical, pathological, and molecular studies conducted to analyse and determine the origin of CUP. The main strategies for patient management and treatment, by both clinicians and pathologists, are also addressed
RESUMEN
No disponible
Asunto(s)

Texto completo: 1 Colección: 06-national / ES Base de datos: IBECS Asunto principal: Neoplasias Primarias Desconocidas / Metástasis de la Neoplasia / Neoplasias Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Clin. transl. oncol. (Print) Año: 2018 Tipo del documento: Article

Texto completo: 1 Colección: 06-national / ES Base de datos: IBECS Asunto principal: Neoplasias Primarias Desconocidas / Metástasis de la Neoplasia / Neoplasias Tipo de estudio: Diagnostic_studies / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Clin. transl. oncol. (Print) Año: 2018 Tipo del documento: Article